DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on August 25, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

First Quarter Performance Report
December 29, 2020

Released for Fiscal Year
2020-2021
Continue reading


Notification of Renewal Deadline Extension
December 29, 2020

State Surgeon General Scott A. Rivkees issued Emergency Order 20-015 granting licensure renewal extensions Continue reading